Professor Victoria Elegant is based in Hong Kong for Amgen and is Vice-President, JAPAC Regional Medical Head, and Site Head, China Research Site, Shangha. Prior to Amgen, Professor Elegant was the Vice-President, Regulatory and Medical Affairs, APAC, based in Shanghai for 10 years for Baxter, and Vice President, Medical Affairs, Asia for Baxalta.  

Professor Elegant is a Fellow of the Faculty of Pharmaceutical Medicine UK (FPM), member of the FPM International Committee, and is an Adjunct Professor, Faculty of Medicine and member of the Board of Studies for the Masters in Pharmaceutical Medicine at the  University of New South Wales, Sydney, Australia.  

She has published and spoken extensively on regulatory affairs, medical affairs and clinical development in the Asia Pacific region  and is President of the Asia Pacific chapter of the Medical Affairs Professional Society (MAPS). She is on the biotech advisory board to the Hong Kong Stock Exchange.  

Professor Elegant holds a medical degree from the University of London, and is passionate about improving standards of care and outcomes for patients in Asia. She is also involved in initiatives to support women in leadership.